Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
256-270 of 422
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Charles Turck, PharmD, BCPS, BCCCP
Evandro Bezerra, MD
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley
Hallie Blevins, PhD
Marlene Mimi Maeusli, PhD.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Balazs Halmos, MD, MS
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Deep Breaths: Updates from CHESTDiagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
Gerard A. Silvestri MD, MS
Jeffrey B. Velotta, MD, FACS
Anne Gonzalez, MD, M.Sc.
Optimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Deep Breaths: Updates from CHESTOptimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
Gerard A. Silvestri MD, MS
Fabien Maldonado, MD, FCCP
Adam H. Fox, MD, MSc
- advertisement
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Balazs Halmos, MD, MS
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Kathleen N. Moore, MD
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Marlene Mimi Maeusli, PhD.
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Kathleen N. Moore, MD
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Kathleen N. Moore, MD
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Ryan Quigley
- advertisement
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Project Oncology®From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Ryan Quigley
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
